Position in MRK
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$10,964,776
+$1,936,893 QoQ
Shares Held
85,329
+13.7% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#716
of 3,769 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Vest Financial, LLC holds $177,449,874 across 8 Drug Manufacturers - General names. MRK ranks #4 (6.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
268,319 | $67,519,792 | |
| 2 | JNJ |
Johnson & Johnson
|
259,276 | $65,848,324 | |
| 3 | LLY |
ELI LILLY & Co
|
14,258 | $17,101,473 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
85,329 | $10,964,776 | |
| 5 | AMGN |
Amgen Inc
|
23,056 | $8,349,037 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
24,740 | $3,125,651 | |
| 7 | PFE |
Pfizer Inc
|
101,513 | $2,444,433 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
36,383 | $2,096,388 |
All Filings in MRK
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $10,964,776 | 85,329 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $9,027,883 | 75,051 | Shares | Defined | 2026-04-24 | |
| 2025-12-31 | $7,631,770 | 72,504 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $4,723,664 | 56,281 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $4,763,847 | 60,180 | Shares | Defined | 2025-07-25 | |
| 2025-03-31 | $3,531,337 | 39,342 | Shares | Sole | 2025-04-11 | |
| 2024-12-31 | $1,209,378 | 12,157 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $1,203,281 | 10,596 | Shares | Sole | 2024-10-18 | |
| 2024-06-30 | $435,404 | 3,517 | Shares | Sole | 2024-08-08 | |
| 2024-03-31 | $481,089 | 3,646 | Shares | Defined | 2024-04-30 | |
| No filing history on record for this holder in this stock. | ||||||